Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on May 28, 2025
Key Trend Shaping The Radiation Oncology Market In 2025: Advanced Radiation Therapy Systems Enhancing Patient Outcomes
EIN Presswire
·
May 28, 2025
The Business Research Company’s Radiation Oncology Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- What Is The Forecasted Growth Of The Radiation Oncology …
Niemann-Pick Disease Type C Treatment Market Forecast 2025-2034: Growth Drivers, Market Share, Segments, and Trends
EIN Presswire
·
May 28, 2025
The Business Research Company's Niemann-Pick Disease Type C Treatment Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- In recent years, the Niemann- …
Personalized Or Customized Skin Care Global Market Report 2025
EIN Presswire
·
May 28, 2025
The Business Research Company’s Personalized Or Customized Skin Care Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research Company’ …
Innovative Therapies Drive Better Outcomes in Idiopathic Intracranial Hypertension Treatment Market, 2025–2034
EIN Presswire
·
May 28, 2025
The Business Research Company's Idiopathic Intracranial Hypertension Treatment Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2035 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business …
Global Retractable Needle Safety Syringes Market Insights 2025: Key Trends, Market Size, And Growth Forecast
EIN Presswire
·
May 28, 2025
The Business Research Company's Global Retractable Needle Safety Syringes Market Insights 2025: Key Trends, Market Size, And Growth Forecast LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research Company’s …
Retinal Detachment Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034
EIN Presswire
·
May 28, 2025
The Business Research Company's Retinal Detachment Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report …
Key Market Driver in Pelvic Cancer Induced Hemorrhagic Cystitis Industry 2025: Rise in Treatments Causing Bladder Issues
EIN Presswire
·
May 28, 2025
The Business Research Company’s Pelvic Cancer Induced Hemorrhagic Cystitis Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research …
Orthopedic 3D Printing Devices Rapidly Growing, Global Market Expected To Reach $2.26 Billion By 2025
EIN Presswire
·
May 28, 2025
The Business Research Company's Orthopedic 3D Printing Devices Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The orthopedic 3D printing devices …
Orthopedic Splints Global Market Report 2025: Growing Adoption of Advanced Technologies Fuels Market Expansion
EIN Presswire
·
May 28, 2025
The Business Research Company's Orthopedic Splints Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The orthopedic splints market has been …
Konverge AI Achieves ISO 27001 Certification, Strengthening Commitment to Enterprise Data Security
EIN Presswire
·
May 28, 2025
The certification affirms Konverge AI’s preparedness to safeguard sensitive data in accordance with global enterprise security standards. IRVINE, CA, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- Konverge AI, a leading provider of AI and data …
Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with Schizophrenia at American Society of Clinical Psychopharmacology 2025
GlobeNewswire
·
May 28, 2025
Tokyo, Japan and Cambridge, UK, 29 May 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) notes that Neurocrine Biosciences, Inc. announced that it had presented new positive data from the Phase 2 study of NBI-1117568 in adults with …
Key Market Driver in intravenous iron drugs Industry 2025: Rising Prevalence Of Risk Factors, Associated Mortality Rates
EIN Presswire
·
May 28, 2025
The Business Research Company's Intravenous Iron Drugs Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest …
Comprehensive Insights Of The Global Image-Guided And Robot-Assisted Surgical Procedures Market: Key Drivers, Trends
EIN Presswire
·
May 28, 2025
The Business Research Company's Image Guided And Robotic Assisted Procedures Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research …
CORRECTION: Streamex and BioSig Appoint Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (CIO)
GlobeNewswire
·
May 28, 2025
Los Angeles, CA and Vancouver, BC, May 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig") and Streamex Exchange Corporation ("Streamex"), collectively referred to as the combined company, today announced the appointment of …
Rakovina Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations
GlobeNewswire
·
May 28, 2025
VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”) announces that in accordance with the terms of an indenture entered into between the Company and Odyssey Trust …
Fate Therapeutics Announces Phase 1 Data Presentation of FT819 Off-the-Shelf CAR T-cell Product Candidate for SLE at EULAR 2025 Congress
GlobeNewswire
·
May 28, 2025
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived off-the-shelf cellular …
SOMAÍ Launches New HCP Portals and AI Assistant as Part of Global Website Enhancements
EIN Presswire
·
May 28, 2025
SOMAÍ has announced the launch of dedicated HCP portals in Australia, Germany, and the United Kingdom, as well as the rollout of a new AI-powered assistant LISBON, PORTUGAL, May 28, 2025 /EINPresswire.com/ -- SOMAÍ, a leading EU-GMP-certified vertically …
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution
GlobeNewswire
·
May 28, 2025
• KHINDIVI is the first and only FDA-approved hydrocortisone oral solution • Commercial launch expected the week of June 2nd • Eton expects combined peak sales of KHINDIVI and ALKINDI SPRINKLE® (hydrocortisone) oral granules to exceed $50 million DEER PARK …
IMUNON Closes Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules
GlobeNewswire
·
May 28, 2025
$3.25 million upfront with up to an additional $6.5 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants LAWRENCEVILLE, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company …
Nyxoah to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
Nyxoah to Present at the Jefferies Global Healthcare Conference Mont-Saint-Guibert, Belgium – May 28, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops …